---
title: "MDR rule 19: Nanomaterials"
url: https://normiq.app/en/classification/mdr/rule-19
language: en
updated: 2026-11-15
---

# MDR rule 19: Nanomaterials

MDR · Annex VIII, Section 7.6 · SPECIAL RULES

Updated on November 15, 2026

## Official text

All devices incorporating or consisting of nanomaterial are classified as:

- class III if they present a high or medium potential for internal exposure;
- class IIb if they present a low potential for internal exposure; and
- class IIa if they present a negligible potential for internal exposure.

MDR, Annex VIII, Section 7.6, consolidated version of July 19, 2026.

Short link: [normiq.app/en/mdr/annexe/viii/19](https://normiq.app/en/mdr/annexe/viii/19)

## In plain words

A device incorporating or consisting of nanomaterial is classified by its potential for internal exposure: class III if high or medium, class IIb if low, class IIa if negligible. Nanomaterial is defined in Article 2, point 18.

Explanation written by Normiq; only the official text above is authoritative.

## Definitions the rule relies on

- MDR, Article 2, point 18

  ‘nanomaterial’ means a natural, incidental or manufactured material containing particles in an unbound state or as an aggregate or as an agglomerate and where, for 50 % or more of the particles in the number size distribution, one or more external dimensions is in the size range 1-100 nm;

  - Fullerenes, graphene flakes and single-wall carbon nanotubes with one or more external dimensions below 1 nm shall also be deemed to be nanomaterials;

## Examples from the MDCG guidance

The guidance lists these examples under rule 19 (MDCG 2021-24 Rev.1). It is not legally binding, and the class always depends on the intended purpose of the device (Annex VIII, Section 3.1).

### Class IIa

- Solution administration set made of non-degradable polymer, with nanomaterial embedded in the polymer matrix

  MDCG 2021-24 Rev.1, 4.2, Rule 19, p. 55

### Class IIb

- Solution administration set made of non-degradable polymer, with a strongly bound nano-coating

  MDCG 2021-24 Rev.1, 4.2, Rule 19, p. 55

### Class III

- Bone fillers with nanomaterials in their formulation (not polymerized before blood/tissue contact, and degradable)

  MDCG 2021-24 Rev.1, 4.2, Rule 19, p. 55

## Classes and Normiq roadmaps

Rule 19 assigns: Class IIa, Class IIb, Class III. For each, the Normiq roadmap on every market where Annex VIII applies.

### Class IIa

- [European Union 15 phases · 66 steps · estimated duration 240 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iia)
- [Switzerland 16 phases · 74 steps · estimated duration 120 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iia)
- [European Union and Switzerland 17 phases · 82 steps · estimated duration 300 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iia)

### Class IIb

- [European Union 15 phases · 68 steps · estimated duration 360 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iib)
- [Switzerland 16 phases · 77 steps · estimated duration 180 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iib)
- [European Union and Switzerland 17 phases · 85 steps · estimated duration 420 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iib)

### Class III

- [European Union 15 phases · 68 steps · estimated duration 540 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iii)
- [Switzerland 16 phases · 77 steps · estimated duration 270 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iii)
- [European Union and Switzerland 17 phases · 85 steps · estimated duration 630 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iii)

## The same rule in Switzerland

> Devices shall be divided into classes I, IIa, IIb and III, taking into account the intended purpose of the devices and their inherent risks. This classification must comply with the provisions of Annex VIII to EU-MDR, taking account of the implementing acts of the European Commission listed in Annex 5a.

Fedlex’s English translation, which has no legal force: the ordinance is official only in French, German and Italian.

[Art. 15 MedDO](https://www.fedlex.admin.ch/eli/cc/2020/552/en#art_15)

The families of rules, the cross-cutting criteria, Rule 11 and common pitfalls are explained in the guide: [MDR classification: the 22 rules of Annex VIII explained](https://normiq.app/en/guides/classification-mdr-annexe-viii)

## Classify your device

The tool asks the questions of the 22 rules of the MDR, one at a time, and gives the indicative class with the rule and its text.

[Open the classification tool](https://normiq.app/en/classification#outil)

## Official sources

- [MDR, consolidated version of July 19, 2026 (02017R0745-20260719), EUR-Lex](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0745-20260719)
- [MDCG 2021-24 Rev.1, “Guidance on classification of medical devices”, April 2026, p. 55](https://health.ec.europa.eu/document/download/cbb19821-a517-4e13-bf87-fdc6ddd1782e_en?filename=mdcg_2021-24_en.pdf)
